Abstract
In conclusion, rapid advances in our understanding of the molecular basis of T cell recognition have revealed a number of approaches for immune intervention in autoimmune disease. Each procedure has been tried and tested in experimental models. Characterization of T cell recognition in human autoimmune disease is a step behind. However, their success in experimental models indicates that MHC-blocking peptides will find use both in identification of restriction elements for disease and in the prevention and treatment of human autoimmune conditions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
